Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swedish (OMX) Medical Supplies Industry Analysis

UpdatedApr 15, 2025
DataAggregated Company Financials
Companies8
  • 7D0.4%
  • 3M-16.8%
  • 1Y-0.07%
  • YTDn/a

Over the last 7 days, the Medical Supplies industry has dropped 3.4%, driven by Vimian Group declining 8.6%. However, the industry is down 3.2% over the past year. Earnings are forecast to grow by 42% annually.

Industry Valuation and Performance

Has the Swedish Medical Supplies Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 15 Apr 2025SEK 60.8bSEK 20.4bSEK 613.8m66.4x99x3x
Thu, 13 Mar 2025SEK 34.5bSEK 5.4bSEK 231.7m72.4x149x6.4x
Sat, 08 Feb 2025SEK 38.0bSEK 5.2bSEK 29.6m3628x1284.4x7.2x
Mon, 06 Jan 2025SEK 39.0bSEK 5.2b-SEK 5,401,587.573561.9x-7223.1x7.5x
Wed, 04 Dec 2024SEK 40.7bSEK 5.2bSEK 9.5m3974.5x4298.8x7.8x
Fri, 01 Nov 2024SEK 40.0bSEK 5.2b-SEK 38,166,408.163950.5x-1047.3x7.6x
Sun, 29 Sep 2024SEK 42.6bSEK 5.0b-SEK 33,951,729.59173.3x-1253.5x8.6x
Tue, 27 Aug 2024SEK 42.2bSEK 5.0b-SEK 30,354,587.74168.8x-1390.5x8.4x
Thu, 25 Jul 2024SEK 38.1bSEK 5.0b-SEK 79,236,803.11164.9x-480.6x7.6x
Sat, 22 Jun 2024SEK 35.4bSEK 4.8b-SEK 153,178,237.83168.2x-231x7.4x
Mon, 20 May 2024SEK 34.7bSEK 4.9b-SEK 149,521,323.50163x-232.2x7.1x
Wed, 17 Apr 2024SEK 31.1bSEK 4.8b-SEK 171,432,789.59130.4x-181.4x6.4x
Fri, 15 Mar 2024SEK 27.3bSEK 4.7b-SEK 175,309,599.07113.8x-155.5x5.8x
Sun, 11 Feb 2024SEK 25.3bSEK 4.6b-SEK 336,689,903.2192.5x-75.2x5.5x
Tue, 09 Jan 2024SEK 27.0bSEK 4.6b-SEK 416,126,437.00429.1x-64.9x5.9x
Thu, 07 Dec 2023SEK 24.7bSEK 4.6b-SEK 416,419,175.00360.4x-59.3x5.3x
Sat, 04 Nov 2023SEK 22.9bSEK 4.6b-SEK 513,556,250.00317.2x-44.7x5x
Mon, 02 Oct 2023SEK 22.9bSEK 4.5b-SEK 492,885,420.00318x-46.4x5x
Wed, 30 Aug 2023SEK 25.5bSEK 4.6b-SEK 499,937,658.00311.2x-51.1x5.5x
Fri, 28 Jul 2023SEK 25.3bSEK 4.4b-SEK 412,987,870.00343x-61.3x5.8x
Sun, 25 Jun 2023SEK 28.2bSEK 4.4b-SEK 423,083,375.00332.4x-66.7x6.5x
Tue, 23 May 2023SEK 28.8bSEK 4.3b-SEK 428,023,884.00322.8x-67.4x6.8x
Thu, 20 Apr 2023SEK 28.7bSEK 4.0b-SEK 412,789,715.00411.2x-69.5x7.2x
Sat, 18 Mar 2023SEK 25.0bSEK 3.9b-SEK 416,041,050.00396.6x-60.1x6.4x
Mon, 13 Feb 2023SEK 25.7bSEK 3.6bSEK 52.0m69.2x494.8x7.1x
Wed, 11 Jan 2023SEK 24.0bSEK 3.5bSEK 52.7m65.1x455.4x6.8x
Fri, 09 Dec 2022SEK 25.9bSEK 3.5bSEK 48.1m79.2x538.4x7.5x
Sun, 06 Nov 2022SEK 25.7bSEK 3.2bSEK 70.5m74.1x364.9x8x
Tue, 04 Oct 2022SEK 19.8bSEK 3.1bSEK 61.9m53.8x320.4x6.5x
Thu, 01 Sep 2022SEK 26.3bSEK 3.0bSEK 62.4m72.1x420.7x8.6x
Sat, 30 Jul 2022SEK 32.0bSEK 2.8b-SEK 106,852,620.00290.5x-299.2x11.3x
Mon, 27 Jun 2022SEK 35.8bSEK 3.0b-SEK 220,158,666.00449.8x-162.4x12x
Wed, 25 May 2022SEK 35.9bSEK 2.7b-SEK 194,073,333.00282.2x-184.9x13.4x
Fri, 22 Apr 2022SEK 48.8bSEK 2.6b-SEK 167,852,940.00408.3x-290.5x18.6x
Price to Earnings Ratio

-290.5x


Total Market Cap: SEK 48.8bTotal Earnings: -SEK 167,852,940.00Total Revenue: SEK 2.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Medical Supplies Industry Price to Earnings3Y Average -355x202320242025
Current Industry PE
  • Investors are optimistic on the Swedish Health Care Supplies industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 100x which is higher than its 3-year average PE of -356x.
  • The 3-year average PS ratio of 7.4x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
  • Total earnings for the Health Care Supplies industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 98% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Comparison

How does Swedish Medical Supplies compare with similar industries?

SE Market6.78%
Healthcare4.52%
Medical Equipment4.05%
Medical Supplies0.37%
Medical Equipment6.21%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
XVIVO Xvivo PerfusionSEK 277.6011.7%
+SEK 913.5m		-16.4%PE50.8x
OSSD OssDsignSEK 13.7825.7%
+SEK 275.4m		39.1%PS10x
BACTI B Bactiguard HoldingSEK 31.9022.2%
+SEK 203.3m		-54.3%PS4.5x
BIOWKS Bio-Works TechnologiesSEK 1.3928.8%
+SEK 24.2m		-66.2%PS4.2x
BIBB BiBBInstrumentsSEK 2.722.6%
+SEK 2.8m		-42.4%PB3.9x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

OSSD

SEK 13.78

OssDsign

7D

25.7%

1Y

39.1%

author-image

Pure Play Orthobiologics Will Expand US Healthcare Access

Apr 07 Strategic shift to orthobiologics boosts growth and operational efficiency, enhancing future revenue and sustaining high net margins.

BACTI B

SEK 31.90

Bactiguard Holding

7D

22.2%

1Y

-54.3%

Bactiguard Holding AB (publ) (STO:BACTI B) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Apr 05
Bactiguard Holding AB (publ) (STO:BACTI B) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

XVIVO

SEK 277.60

Xvivo Perfusion

7D

11.7%

1Y

-16.4%

Xvivo Perfusion AB (publ)'s (STO:XVIVO) Intrinsic Value Is Potentially 36% Above Its Share Price

Apr 03
Xvivo Perfusion AB (publ)'s (STO:XVIVO) Intrinsic Value Is Potentially 36% Above Its Share Price

BIOWKS

SEK 1.39

Bio-Works Technologies

7D

28.8%

1Y

-66.2%

BIBB

SEK 2.72

BiBBInstruments

7D

2.6%

1Y

-42.4%

VIMIAN

SEK 37.90

Vimian Group

7D

-4.3%

1Y

17.7%

BIOVIT

SEK 0.12

Bio Vitos Pharma

7D

8.6%

1Y

-94.8%

S2M

SEK 0.012

S2Medical

7D

24.0%

1Y

-83.2%